Real-life efficacy and predictors of response to immunotherapy in pituitary tumors: a cohort studyMirela Diana Ilie, Gérald Raverot, Chiara Villa et al.|European Journal of Endocrinology|2022Cited by 52
BRAF and MEK inhibitor targeted therapy in papillary craniopharyngiomas: a cohort studyDario De Alcubierre, Emmanuel Jouanneau, Grigorios Gkasdaris et al.|European Journal of Endocrinology|2024Cited by 23
Radiotherapy Plus Procarbazine, Lomustine, and Vincristine Versus Radiotherapy Plus Temozolomide for <i>IDH</i>-Mutant Anaplastic Astrocytoma: A Retrospective Multicenter Analysis of the French POLA CohortVincent Esteyrie, Pola Network, Elizabeth Cohen‐Jonathan Moyal et al.|The Oncologist|2021Cited by 21
Un carcinome hypophysaire somatotropeM. Vialon, Philippe Caron, Adam S. Bernard et al.|Annales d Endocrinologie|2020Cited by 0
B-RAF and MEK inhibitor argeted therapy in papillary craniopharyngiomas: results from the French national multicenter studyAlcubierre Dario De, Emmanuel Jouanneau, Grigorios Gkasdaris et al.|Endocrine Abstracts|2024Cited by 0